Glyphic Biotechnologies

Berkeley, CA · Founded 2021 · Privately Held (backing)

Operator of a biotechnology platform intended to increase binding affinity and improve consistency to help create personalized, precision cancer vaccines for patients of all backgrounds. Glyphic Biotechnologies is based in Berkeley, CA and was founded in 2021. Its last reported valuation was $155 million in Sep 2025. It has raised $43.8 million.

Last reported valuation

$155.0M

Oct 2026

Priced at

—

Total raised

$43.8M

Last round

—

How much has Glyphic Biotechnologies raised?

$43.8Macross 0 recorded rounds

Free account

More of Glyphic Biotechnologies with a free account

·The complete investor list: 35 names
·Watch Glyphic Biotechnologies: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Glyphic Biotechnologies investors

35 investors are on record for Glyphic Biotechnologies, including Gaingels, Calm Ventures, Valor Equity Partners and SBXi. By type, the record holds 11 venture capital firms and 1 family office.

For fundraisers

Raising for a company like Glyphic Biotechnologies?

35 investors have backed Glyphic Biotechnologies.

See all 35 investors →

Frequently asked about Glyphic Biotechnologies

How much has Glyphic Biotechnologies raised?: Glyphic Biotechnologies has raised $43.8M in total across 0 recorded funding rounds.